NEWS

A major milestone – a harmonized approach to product carbon footprint data

12 February 2024
Sustainability
Rebecca Tushingham
Global Change Facilitator

The key goal of the biopharma industry is to speed up the development of innovative medicines and ensure their availability to a greater number of people. The longevity of the industry relies on sustainable practices. Driving environmental sustainability is therefore a priority.

The BioPhorum Environmental Sustainability Roadmap outlines the BioPhorum Sustainability vision of improving patient health by providing biopharmaceuticals while respecting the planet and responsibly using its resources.

To help deliver this vision, license holders, contract development and manufacturing organizations (CDMOs),  and key suppliers have committed to defining a common industry approach for calculating and exchanging environmental impact data, through the development of a product carbon footprint (PCF) framework for the biopharma industry.

The framework intends to create a harmonized industry approach to calculating supplier PCFs that aligns with and complements existing standards and methodologies, providing additional guidance specific to the biopharma industry where gaps are identified. T[LP5] he drivers for the framework are to allow future-proofing to respond to forthcoming regulations and encourage eco-design through the supply chain.

To maintain momentum and gain industry support, BioPhorum has developed a position statement called Developing a harmonized approach to product carbon footprint data for the biopharma industry.

“What a major milestone!” said Matteo Alaria, Head of Sustainability BPS at Sartorius. “A clear and aligned commitment to develop a framework on Product Carbon Footprint was needed in our industry. This will reduce complexity, simplifying progress towards our decarbonization goals.”

The position statement outlines the context for the use of PCF data for assessing environmental impact and use cases for PCFs. The emphasis on transparency enables a deeper understanding of greenhouse gas emission hotspots in the supply chain. Armed with this knowledge, license holders, CDMOs, and suppliers can take a collaborative approach to identifying opportunities for emissions reductions.

Through the development of this framework for self-declaration on product sustainability performance for the biopharma industry, the group aims to deliver:

  • A harmonized industry approach to calculating PCFs of supplies into the drug manufacturing process that aligns with and complements existing standards and methodologies
  • Additional guidance specific to the biopharma industry where this is required
  • A framework that ensures biopharma is well-positioned and equipped to meet upcoming industry and regulatory requirements and aligns to future industry guidance, where applicable
  • A clear industry commitment to tackling environmental impact in a holistic way.

Do you want to help shape the development of a robust product carbon footprint framework for our industry?

For more information, download the paper here and contact Rebecca Tushingham, Senior Global Change Facilitator, at rebecca.tushingham@biophorum.com

Waves
NEWS
A wave of redesign to protect against water scarcity
Amgen logo against skyline and buildings
NEWS
BioPhorum introduces – Sustainability In conversation with Amgen
Sustainabilty Lightbulb
NEWS
How are you improving your environmental sustainability performance?
Question Mark On Green Background
NEWS
BioPhorum survey shows the scale of industry’s indirect carbon emissions challenge
DNA pink background
NEWS
Registering innovative raw materials using QbD principles: Protein A resins

Advanced Therapy Medicinal Products

Advanced Therapy Medicinal Products support the quest for better and faster development of cell, gene and RNA therapies​ through connecting therapy developers, contract manufacturing, and testing organizations to gain an understanding and respond to the challenges faced by the advanced therapeutics industry.

Development Group

Development Group accelerates and improves the development process of biopharmaceutical medicines for the benefit of the patient. Replacing isolation with collaboration by providing a “safe” space where subject matter experts can work on sharing solutions and best practice on emerging industry trends, implementation of new technologies and common issues whilst ensuring their intellectual property and confidentiality is protected.

Drug Substance

Drug Substance advances excellence in drug substance manufacturing and testing, acting as an industry voice to accelerate technology adoption, implement post-approval change more rapidly and increase confidence in maintaining compliance.

Fill Finish

Fill Finish accelerates development and acceptance of sustainable world-class filling and packaging operations for drug product which meets the future needs of patients. Through innovative solutions resulting from the sharing of expertise, we can overcome common performance challenges and deliver on quality and regulatory compliance.

Information Technology

Information Technology accelerates digital maturity across the ​global pharmaceutical manufacturing industry.

Quality

BioPhorum Quality provides a dedicated, safe space for quality professionals from biomanufacturers and contract organizations to coalesce and enhance effective collaboration to address shared industry challenges.

Regulatory-CMC

Regulatory CMC brings leaders together who have a common goal – to improve access to medicines through innovation in the Regulatory ecosystem. It provides a dedicated space for strategic leadership and a coordinated industry voice, to move from divergence to convergence.

Supply Chain to Patient

Supply Chain to Patient transforms the performance of global pharmaceutical clinical and commercial outbound supply chains through industry collaboration by creating transparent patient-centric, resilient and agile E2E supply chains, that consistently deliver high-quality medicines ensuring an uninterrupted supply to patients.

Supply Partner

Supply Partner is a trusted advisory group and collaboration that is the engine for driving change across the global industry for all things relevant to the inbound supply chain. Addressing the challenges of complexity, resilience, cost, sustainability, and innovation.

Sustainability

Sustainability enables the industry’s transition to a low carbon, circular future – supporting members to improve patient health while respecting the planet. We activate multi-disciplinary teams drawn from our network to deliver environmental sustainability improvements across the value chain.

Technology Strategy

Technology Strategy acts as one voice of the industry to define strategy, accelerate technology transformation and support technology translation and adoption. With a purpose of enabling the future state of flexible, resilient, sustainable end-to-end biomanufacturing.

DOWNLOAD
An industry perspective on understanding AAV capsid content variants
Needle On Yellow Background
EXTERNAL-RESOURCE
An intercompany perspective on practical experiences of predicting, optimizing and analyzing high concentration biologic therapeutic formulations
DOWNLOAD
The Drug Substance 2.0 Strategic Value Framework
Coloured dots on teal, next to vial
DOWNLOAD
BioPhorum’s holistic approach to container closure integrity
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
NEWS
Inaugural BioPhorum Quality face to face – get involved
PODCAST
The next step in building regulatory as a capability to enable strategic innovation across the BioPhorum community
PODCAST
Delivering a Cell and Gene Therapy Outbound Supply Chain Pathway for the Industry
DNA and Earth on blue background
DOWNLOAD
A vision for the biopharmaceutical industry’s inbound supply chain
NEWS
A major milestone – a harmonized approach to product carbon footprint data
Technology Roadmap V 2.0
DOWNLOAD
BioPhorum Technology Roadmapping roadmap vision 2.0

Publications

Documents including best practices, vision statements and peer reviewed papers to help you take value back to your business.

Webinars

Discussing all aspects of the biopharmaceutical industry, from digitization and knowledge management to raw materials, supply chain, sustainability and more. Learn from the perspectives of those at the forefront of the industry.

Podcasts

BioPhorum Connect is our podcast series that keeps you up to date with the latest news and trends in the biopharmaceutical industry. From experienced professionals to thought leaders, these podcasts bring you the insights and perspectives of experts from around the world.

Tools

A variety of resources including design tools and user requirement specifications to help you improve and streamline your business processes.

Benchmarks and Surveys

Research conducted among the BioPhorum membership providing evidence to support change and identify best practice.

Browse all

Access a variety of free tools and papers and other resources designed to provide you with up-to-date information and insights to help you make informed decisions and maximize your success. Access our resources today and start making improving and streamlining your business processes.

WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
WEBINAR
Bioreactivity testing in single-use system biomanufacturing
Magnifying glass over a tablet all coloured blue
DOWNLOAD
Digital Plant Maturity Model 3.0
WEBINAR
Bioreactivity testing in single-use system biomanufacturing